Fny Investment Advisers, LLC Genocea Biosciences, Inc. Transaction History

Fny Investment Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$2.06 - $2.82 $391,400 - $535,800	-190,000 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$2.35 - $4.01 $23,500 - $40,100	-10,000 Reduced 5.0%	190,000 $514,000
Q3 2020 Oct 09, 2020	SELL	$1.81 - $5.53 $181,000 - $553,000	-100,000 Reduced 33.33%	200,000 $458,000
Q1 2020 Apr 09, 2020	BUY	$1.26 - $2.73 $31,500 - $68,250	25,000 Added 9.09%	300,000 $516,000
Q4 2019 Jan 10, 2020	BUY	$2.05 - $2.82 $45,099 - $62,040	22,000 Added 8.7%	275,000 $569,000
Q3 2019 Oct 25, 2019	BUY	$2.9 - $4.07 $343,940 - $482,702	118,600 Added 88.24%	253,000 $733,000
Q2 2019 Jul 24, 2019	BUY	$3.47 - $6.71 $466,368 - $901,824	134,400 New	134,400 $526,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.